SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0000892712-11-000988
Filing Date
2011-12-09
Accepted
2011-12-09 17:13:51
Documents
1
Filing Date Changed
2011-12-09

Document Format Files

Seq Description Document Type Size
1 biosante13da.htm SC 13D/A 520698
  Complete submission text file 0000892712-11-000988.txt   522333
Mailing Address 8400 NORMANDALE LAKE BOULEVARD SUITE 1450 BLOOMINGTON MN 55437
Business Address 8400 NORMANDALE LAKE BOULEVARD SUITE 1450 BLOOMINGTON MN 55437 9528410400
KOPP INVESTMENT ADVISORS LLC (Filed by) CIK: 0000884306 (see all company filings)

IRS No.: 411663810 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60689 | Film No.: 111254094
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1